Pfizer Inc (PFE)
25.13
+0.19
(+0.76%)
USD |
NYSE |
Nov 21, 16:00
25.10
-0.03
(-0.12%)
After-Hours: 20:00
Pfizer Total Liabilities (Quarterly): 126.92B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 126.92B |
| June 30, 2024 | 128.22B |
| March 31, 2024 | 128.54B |
| December 31, 2023 | 137.21B |
| September 30, 2023 | 117.82B |
| June 30, 2023 | 120.88B |
| March 31, 2023 | 94.38B |
| December 31, 2022 | 101.29B |
| September 30, 2022 | 102.46B |
| June 30, 2022 | 107.82B |
| March 31, 2022 | 101.16B |
| December 31, 2021 | 104.01B |
| September 30, 2021 | 103.22B |
| June 30, 2021 | 99.60B |
| March 31, 2021 | 89.95B |
| December 31, 2020 | 90.76B |
| September 30, 2020 | 113.49B |
| June 30, 2020 | 113.37B |
| March 31, 2020 | 101.00B |
| December 31, 2019 | 104.15B |
| September 30, 2019 | 105.05B |
| June 30, 2019 | 96.28B |
| March 31, 2019 | 96.26B |
| December 31, 2018 | 95.66B |
| September 30, 2018 | 96.17B |
| Date | Value |
|---|---|
| June 30, 2018 | 94.86B |
| March 31, 2018 | 94.07B |
| December 31, 2017 | 100.14B |
| September 30, 2017 | 111.04B |
| June 30, 2017 | 109.86B |
| March 31, 2017 | 110.04B |
| December 31, 2016 | 111.78B |
| September 30, 2016 | 114.83B |
| June 30, 2016 | 107.59B |
| March 31, 2016 | 99.58B |
| December 31, 2015 | 102.38B |
| September 30, 2015 | 103.74B |
| June 30, 2015 | 93.70B |
| March 31, 2015 | 93.05B |
| December 31, 2014 | 95.94B |
| September 30, 2014 | 93.06B |
| June 30, 2014 | 95.66B |
| March 31, 2014 | 93.74B |
| December 31, 2013 | 95.48B |
| September 30, 2013 | 97.17B |
| June 30, 2013 | 100.36B |
| March 31, 2013 | 104.57B |
| December 31, 2012 | 104.12B |
| September 30, 2012 | 100.49B |
| June 30, 2012 | 102.88B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
89.95B
Minimum
Mar 2021
137.21B
Maximum
Dec 2023
109.31B
Average
104.08B
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Johnson & Johnson | 108.13B |
| Eli Lilly and Co | 61.29B |
| Merck & Co Inc | 72.97B |
| Moderna Inc | 3.876B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 219.48B |
| Shareholders Equity (Quarterly) | 92.29B |
| Debt to Equity Ratio | 0.7219 |
| Current Ratio | 1.000 |
| Net Debt Paydown Yield | -0.16% |